X-31223056-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP6BS2_Supporting
The NM_004006.3(DMD):c.9352G>A(p.Ala3118Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000828 in 1,207,202 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000064 ( 0 hom. 2 hem. )
Consequence
DMD
NM_004006.3 missense
NM_004006.3 missense
Scores
1
6
9
Clinical Significance
Conservation
PhyloP100: 6.92
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP6
Variant X-31223056-C-T is Benign according to our data. Variant chrX-31223056-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 811289.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.9352G>A | p.Ala3118Thr | missense_variant | 64/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.9352G>A | p.Ala3118Thr | missense_variant | 64/79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 112027Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34187
GnomAD3 genomes
AF:
AC:
3
AN:
112027
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34187
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183500Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67936
GnomAD3 exomes
AF:
AC:
2
AN:
183500
Hom.:
AF XY:
AC XY:
1
AN XY:
67936
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000639 AC: 7AN: 1095175Hom.: 0 Cov.: 29 AF XY: 0.00000555 AC XY: 2AN XY: 360613
GnomAD4 exome
AF:
AC:
7
AN:
1095175
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
360613
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000268 AC: 3AN: 112027Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34187
GnomAD4 genome
AF:
AC:
3
AN:
112027
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34187
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 09, 2019 | The DMD c.9352G>A; p.Ala3118Thr variant (rs200928985), to our knowledge, is not reported in the medical literature but is reported as a variant of uncertain significance in ClinVar (Variation ID: 520520). This variant is found in the Genome Aggregation Database on 2 out of 183,500 alleles, including 1 hemizygote. The alanine at codon 3118 is moderately conserved and computational analyses (SIFT: tolerated, PolyPhen-2: probably damaging) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the p.Ala3118Thr variant is uncertain at this time. - |
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 10, 2019 | - - |
DMD-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 04, 2024 | The DMD c.9352G>A variant is predicted to result in the amino acid substitution p.Ala3118Thr. This variant has been reported in a cohort of individuals suspected of Duchenne muscular dystrophy or Becker muscular dystrophy; however, detailed clinical information was not available (Kim et al. 2016. PubMed ID: 26743743). This variant is reported in 0.0076% of alleles in individuals of African descent in gnomAD, including one hemizygote in the database. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2024 | The p.A3118T variant (also known as c.9352G>A), located in coding exon 64 of the DMD gene, results from a G to A substitution at nucleotide position 9352. The alanine at codon 3118 is replaced by threonine, an amino acid with similar properties. This variant was described in a Duchenne/Becker muscular dystrophy cohort; however, clinical details were not provided (Kim MJ et al. J Mol Diagn, 2016 Mar;18:253-9). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on data from gnomAD, the A allele has an overall frequency of 0.0011% (2/183500) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.0076% (1/13161) of African/African American alleles. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Duchenne muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 28, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;T;.;.;T;.;.;.;T;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;.;.;.;D;.;D;D;D;.;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N;.;D;D;N;.;N;.;N;D;N;D;D
REVEL
Benign
Sift
Benign
T;T;.;T;T;T;.;D;.;D;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.60, 0.98, 0.023, 1.0, 0.058, 1.0
.;.;.;P;D;B;.;D;.;.;.;B;D;.
Vest4
MVP
MPC
0.040
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at